Long-term stabilization in a patient with nonresected pancreatic carcinoma undergoing chemotherapy

Oncology Research and Treatment

Volumn 19, Issue 4, 1996, Pages 337-339

  Jungius, K P ^a   Queisser W ^a   Queisser U ^a   Georgi, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Carcinoma of the Pancreas; Chemotherapy; FEM regime; Long term stabilization

Indexed keywords

CA 19-9 ANTIGEN; EPIRUBICIN; FLUOROURACIL; MITOMYCIN C;

ADULT; ARTICLE; CASE REPORT; HUMAN; MALE; PANCREAS CARCINOMA; SURVIVAL;

EID: 0029842072     PISSN: 22965270     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218825     Document Type: Article

References (18)

1. Boring CC, Squires TS, Tong T: Cancer statistics 1991, CA-Cancer J Clin 1991;41: 19-36.
2. MacMahon B, Yen S, Trichopoulos D, Warren K, Nardi G: Coffee and carcinoma of the pancreas, N Engl J Med 1981:304:630-633.
3. Wynder E, Hall N, Polansky M: Epidemiology of coffee and pancreatic cancer, Cancer Res 1983:43:3900-3906.
4. Wynder E: An epidemiologic evaluation of the causes of cancer of the pancreas Cancer Res 1975:35:2228-2233.
5. Krain LS: The rising incidence of carcinoma of the pancreas An epidemiologic appraisal, Am J Gastroenterol 1970:54:500-507.
6. Robinson A, Scott J, Rosenfeld D: The occurrence of carcinoma of the pancreas in chronic pancreatitis Radiology 1970;94:289-290.
7. Mainz D, Webster P: Pancreatic carcinoma, A review of etiologic considerations Am J Dig Dis 1974:19:459.
8. Mancuso T, El-Attar A: Cohort study of workers exposed to beta-naphthylamine and benzidine, J Occup Med 1967;9:277-285.
9. Godjonsson B: Cancer of the pancreas 50 vears of surgery, Cancer 1987:60: 2284-2303.
10. Mallinson CN, Rake MO, Cocking JB, Fox CA, Cwynarski MT, Diffey BL, Jackson GA, Hanley J, Wass VJ: Chemotherapy in pancreatic cancer: Results of a controlled, prospective, randomized, multicenter trial, Br Med J 1980:281: 1589-1591.
11. Smith FP, Hoth DF, Levin B, Karlin DA, MacDonald JS, Woolley PV, Schein PS: 5-Fluorouracil, adriamycin and mitomycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas Cancer 1980;46:2014-2018.
12. Kinsella TJ: Adjuvant radiotherapy in pancreas carcinoma, A reappraisal, Cancer Invest 1988:6:745-746.
13. Sarr MG, Cameron JL: Surgical management of unresectable carcinoma of the pancreas Surgery 1982;91:123-133.
14. Cullinan S, Moertel CG, Wienand HS, Schutt AJ, Krook JE, Foley JF, Norris BD, Kardinal CG, Tschetter LK, Barlow JF: A phase III trial on the therapy of advanced pancreatic carcinoma, Evaluation of the Mallison regime and combined 5-fluorouracil, doxorubicin, and cisplatin, Cancer 1990;65:2207-2212.
15. Nagel GA: Alternative Strategien in der medikamentösen Tumortherapie, Onkologie 1995:18:68-74.
16. Klaassen DJ, MacIntyre JM, Catton GE, Engstrom PF, Moertel CG: Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil, J Clin Oncol 1985:3:373-378.
17. Oster MW, Gray R, Panasci L, Perry MC: Chemotherapy for advanced pancreatic cancer: A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM), Cancer 1986:57:29-33.
18. Bukowski RM, Balcerzak SP, O’Bryan RM, Bonnet JD, Chen TT: Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer, A Southwest Oncological Group Study, Cancer 1983; 52:1557-1582.